The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic analysis and 3-y efficacy and safety update of COMBI-d: A phase 3 study of dabrafenib (D) + trametinib (T) vs D monotherapy in patients (pts) with unresectable or metastatic BRAF V600E/K-mutant cutaneous melanoma.
 
Keith Flaherty
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Jean Jacques Grob
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Research Funding - Roche
 
Georgina V. Long
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Provectus; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MERCK; Novartis; Provectus; Roche/Genentech
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Roche/Genentech
 
Paul D. Nathan
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis
Research Funding - AstraZeneca; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Antoni Ribas
Stock and Other Ownership Interests - Arcus Ventures; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; Kite, a Gilead company
Consulting or Advisory Role - Amgen; Genentech/Roche; MedImmune; Merck; Novartis; Pierre Fabre
 
Caroline Robert
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
 
Dirk Schadendorf
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Grunenthal; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech; Sysmex
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Grunenthal; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech; Sysmex
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech
 
Dennie T Frederick
No Relationships to Disclose
 
Marc R Hammond
Research Funding - Novartis (Inst)
 
Judit Jane-Valbuena
No Relationships to Disclose
 
Xinmeng Jasmine Mu
No Relationships to Disclose
 
Matthew Squires
Employment - Novartis
 
Savina A. Jaeger
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Stephen R. Lane
Employment - GlaxoSmithKline; Johnson & Johnson (I); Novartis
Stock and Other Ownership Interests - GlaxoSmithKline; Johnson & Johnson (I); Novartis
Travel, Accommodations, Expenses - Novartis
Other Relationship - Novartis
 
Bijoyesh Mookerjee
Employment - GlaxoSmithKline; Novartis
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; Incyte; Novartis
 
Levi A. Garraway
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - Boehringer Ingelheim; Foundation Medicine; Novartis; Warp Drive Bio
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute; Dana-Farber Cancer Institute (Inst)
Travel, Accommodations, Expenses - Bayer; Genentech